Use of recombinant Von Willebrand factor during transcatheter aortic valve replacement in a patient with acquired von Willebrand syndrome.
Laurent SattlerOlivier FeugeasUlun CrimizadeSébastien HessLélia GrunebaumDominique DesprezPublished in: Transfusion medicine (Oxford, England) (2021)